{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T11:21:58Z","timestamp":1787829718957,"version":"build-2784847793"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"22","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5,29]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      Breast carcinoma (BC) is a significant oncological issue, categorized based on estrogen receptor (ER) status into ER-positive and ER-negative types. The ER-positive variant relies on hormonal signaling, whereas the ER-negative form is characterized by increased aggressiveness. There exists a potential interplay between plasma metabolites and immune effectors that may influence BC susceptibility, although the underlying mechanisms remain largely undefined. This study employs Mendelian randomization (MR) to elucidate the causal pathways through which plasma metabolites affect both ER-positive and ER-negative BC susceptibility via immune mediators. In the context of ER-positive BC, sphingolipid metabolites (e.g., Sphingomyelin [d18:1\/17:0] concentrations, odds ratio [OR]\u2005=\u20051.299, 95% confidence interval [CI]: 1.140\u20131.480) exhibited positive associations, whereas bile acid metabolites (e.g., Glycochenodeoxycholate 3-sulfate concentrations, OR\u2005=\u20050.876, 95% CI: 0.818\u20130.938) displayed negative correlations; immune phenotypes such as CD8br % leukocyte (OR\u2005=\u20051.165, 95% CI: 1.005\u20131.351) were positively linked. For ER-negative BC, the phosphate-to-tryptophan ratio (OR\u2005=\u20051.371, 95% CI: 1.047\u20131.796) showed a positive correlation, while indolepropionate (OR\u2005=\u20050.762, 95% CI: 0.647\u20130.896) had an inverse relationship; CD28 on CD39\u2005+\u2005CD8br (OR\u2005=\u20051.052, 95% CI: 1.016\u20131.090) demonstrated a positive association. Mediation analyses revealed pathways: In ER-positive BC, 2R,3R-dihydroxybutyrate was mediated through EM DN (CD4\u2212CD8\u2212) %T cell (intermediation fraction 23.4%), and Sphingomyelin via CD38 on transitional cells (7.41%); in ER-negative BC, Dihomo-linoleoylcarnitine was mediated through human leukocyte antigen-DR on CD14+ CD16+ monocytes (9.98%), and homocitrulline through human leukocyte antigen-DR on plasmacytoid dendritic cells (12.7%). Plasma metabolites significantly influence susceptibility to different BC variants by modifying immune effector functions. This study provides genetic evidence supporting interventions targeting the metabolic-immune interface to improve prevention and management strategies. Utilizing publicly available genome-wide association study datasets, we examined 1440 plasma metabolites (identifiers GCST90199621 to GCST90201020), 731 immune phenotypes (ebi-a-GCST90001391 to ebi-a-GCST90002121), and the FinnGen R12 BC cohorts. Instrumental variables were selected based on criteria of\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u20055\u2005\u00d7\u200510\n                      <jats:sup>\u22128<\/jats:sup>\n                      \/10\n                      <jats:sup>\u22127<\/jats:sup>\n                      ,\n                      <jats:italic toggle=\"yes\">r<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      \u2005&lt;\u20050.001, and F-statistic\u2005&gt;\u200510. We employed bidirectional two-sample MR, primarily using inverse-variance weighted methods, supplemented by MR-Egger and other techniques, to assess causal relationships and intermediary roles.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000049014","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T17:07:41Z","timestamp":1780074461000},"page":"e49014","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["The causal role of plasma metabolites in breast cancer susceptibility mediated by immune cells: A two-sample Mendelian randomization analysis"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-0257-4673","authenticated-orcid":false,"given":"Zhe","family":"Sun","sequence":"first","affiliation":[{"name":"First Affiliated Hospital of Kunming Medical University, Kunming, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Ge","sequence":"additional","affiliation":[{"name":"First Affiliated Hospital of Kunming Medical University, Kunming, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Duan","sequence":"additional","affiliation":[{"name":"First Affiliated Hospital of Kunming Medical University, Kunming, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinxian","family":"Qian","sequence":"additional","affiliation":[{"name":"First Affiliated Hospital of Kunming Medical University, Kunming, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Chen","sequence":"additional","affiliation":[{"name":"First Affiliated Hospital of Kunming Medical University, Kunming, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260827","first-page":"287","article-title":"Global burden of female breast cancer: new estimates in 2022, temporal trend and future projections up to 2050 based on the latest release from GLOBOCAN.","volume":"5","author":"Zhang","year":"2025","journal-title":"J Natl Cancer Cent"},{"key":"R2-20260827","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1001\/jamaoncol.2022.7826","article-title":"Estimates and projections of the global economic cost of 29 cancers in 204 countries and territories from 2020 to 2050.","volume":"9","author":"Chen","year":"2023","journal-title":"JAMA Oncol"},{"key":"R3-20260827","doi-asserted-by":"crossref","first-page":"1186892","DOI":"10.3389\/fimmu.2023.1186892","article-title":"Regulation of short-chain fatty acids in the immune system.","volume":"14","author":"Liu","year":"2023","journal-title":"Front Immunol"},{"key":"R4-20260827","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s44324-024-00027-0","article-title":"Lipidomics and metabolomics as potential biomarkers for breast cancer progression.","volume":"2","author":"Carmona","year":"2024","journal-title":"NPJ Metab Health Dis"},{"key":"R5-20260827","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1097\/PSY.0000000000001109","article-title":"Relationships between serum cortisol, RAGE-associated s100A8\/A9 levels, and self-reported cancer-related distress in women with nonmetastatic breast cancer.","volume":"84","author":"Taub","year":"2022","journal-title":"Psychosom Med"},{"key":"R6-20260827","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1038\/s41588-023-01497-6","article-title":"Genome-wide association meta-analysis identifies 17 loci associated with nonalcoholic fatty liver disease.","volume":"55","author":"Chen","year":"2023","journal-title":"Nat Genet"},{"key":"R7-20260827","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1038\/s41588-020-0684-4","article-title":"Complex genetic signatures in immune cells underlie autoimmunity and inform therapy.","volume":"52","author":"Orr\u00f9","year":"2020","journal-title":"Nat Genet"},{"key":"R8-20260827","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s13058-025-02102-w","article-title":"Pre-diagnostic serum metabolome and breast cancer risk: a nested case-control study.","volume":"27","author":"Trinh","year":"2025","journal-title":"Breast Cancer Res"},{"key":"R9-20260827","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/s41419-018-0313-7","article-title":"The carnitine system and cancer metabolic plasticity.","volume":"9","author":"Melone","year":"2018","journal-title":"Cell Death Dis"},{"key":"R10-20260827","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s10549-019-05165-4","article-title":"Breast cancer risk in relation to plasma metabolites among Hispanic and African American women.","volume":"176","author":"Zhao","year":"2019","journal-title":"Breast Cancer Res Treat"},{"key":"R11-20260827","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/s12935-025-03928-2","article-title":"Very long-chain fatty acids accumulate in breast cancer tissue and serum.","volume":"25","author":"Pakiet","year":"2025","journal-title":"Cancer Cell Int"},{"key":"R12-20260827","doi-asserted-by":"crossref","first-page":"891619","DOI":"10.3389\/fonc.2022.891619","article-title":"Circulating carnitine levels and breast cancer: a matched retrospective case-control study.","volume":"12","author":"Zhang","year":"2022","journal-title":"Front Oncol"},{"key":"R13-20260827","doi-asserted-by":"crossref","first-page":"116326","DOI":"10.1016\/j.bcp.2024.116326","article-title":"Reprogramming of urea cycle in cancer: mechanism, regulation and prospective therapeutic scopes.","volume":"228","author":"Ghosh","year":"2024","journal-title":"Biochem Pharmacol"},{"key":"R14-20260827","doi-asserted-by":"crossref","first-page":"189412","DOI":"10.1016\/j.bbcan.2025.189412","article-title":"Reprogramming of amino acid metabolism in breast cancer.","volume":"1880","author":"Wang","year":"2025","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"R15-20260827","doi-asserted-by":"crossref","first-page":"4482","DOI":"10.3390\/ijms26104482","article-title":"Asymmetric dimethylarginine disrupts tumor antigen presentation in breast cancer.","volume":"26","author":"Li","year":"2025","journal-title":"Int J Mol Sci"},{"key":"R16-20260827","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1093\/procel\/pwaf011","article-title":"Amino acid metabolism in breast cancer: pathogenic drivers and therapeutic opportunities.","volume":"16","author":"Liu","year":"2025","journal-title":"Protein Cell"},{"key":"R17-20260827","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/s42255-022-00638-1","article-title":"GAB functions as a bioenergetic and signalling gatekeeper to control T cell inflammation.","volume":"4","author":"Kang","year":"2022","journal-title":"Nat Metab"},{"key":"R18-20260827","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.3181\/0902-MR-77","article-title":"Sphingolipids as determinants of apoptosis and chemoresistance in the MCF-7 cell model system.","volume":"234","author":"Meacham","year":"2009","journal-title":"Exp Biol Med (Maywood)"},{"key":"R19-20260827","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s10549-020-05523-7","article-title":"Significance of glucocorticoid signaling in triple-negative breast cancer patients: a newly revealed interaction with androgen signaling.","volume":"180","author":"Kanai","year":"2020","journal-title":"Breast Cancer Res Treat"},{"key":"R20-20260827","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/bcr2413","article-title":"Androgens and the breast.","volume":"11","author":"Dimitrakakis","year":"2009","journal-title":"Breast Cancer Res"},{"key":"R21-20260827","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.3390\/cancers16234043","article-title":"Regulation of stromal cells by sex steroid hormones in the breast cancer microenvironment.","volume":"16","author":"Yamaguchi-Tanaka","year":"2024","journal-title":"Cancers (Basel)"},{"key":"R22-20260827","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/s41419-024-07222-3","article-title":"FXR deficiency induced ferroptosis via modulation of the CBP-dependent p53 acetylation to suppress breast cancer growth and metastasis.","volume":"15","author":"Huang","year":"2024","journal-title":"Cell Death Dis"},{"key":"R23-20260827","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/s41590-024-01821-0","article-title":"Predictability of B cell clonal persistence and immunosurveillance in breast cancer.","volume":"25","author":"Sammut","year":"2024","journal-title":"Nat Immunol"},{"key":"R24-20260827","doi-asserted-by":"crossref","first-page":"616469","DOI":"10.3389\/fgene.2021.616469","article-title":"Immune cell infiltration-based characterization of triple-negative breast cancer predicts prognosis and chemotherapy response markers.","volume":"12","author":"Lv","year":"2021","journal-title":"Front Genet"},{"key":"R25-20260827","doi-asserted-by":"crossref","first-page":"e153963","DOI":"10.1172\/jci.insight.153963","article-title":"Tumor-infiltrating exhausted CD8+ T cells dictate reduced survival in premenopausal estrogen receptor-positive breast cancer.","volume":"7","author":"Egelston","year":"2022","journal-title":"JCI Insight"},{"key":"R26-20260827","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/cac2.12429","article-title":"Single-cell atlas reveals a distinct immune profile fostered by T cell-B cell crosstalk in triple negative breast cancer.","volume":"43","author":"Ding","year":"2023","journal-title":"Cancer Commun (Lond)"},{"key":"R27-20260827","doi-asserted-by":"crossref","first-page":"1225175","DOI":"10.3389\/fimmu.2023.1225175","article-title":"Experimental and clinical evidence in favour of an effective immune stimulation in ER-positive, endocrine-dependent metastatic breast cancer.","volume":"14","author":"Nicolini","year":"2023","journal-title":"Front Immunol"},{"key":"R28-20260827","doi-asserted-by":"crossref","first-page":"598","DOI":"10.3892\/ol.2025.15344","article-title":"CCL2\/CCR2 signaling pathway in tumorigenesis and metastasis (Review).","volume":"30","author":"Zhang","year":"2025","journal-title":"Oncol Lett"},{"key":"R29-20260827","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12943-024-02208-3","article-title":"Myeloid-derived suppressor cells (MDSCs) in the tumor microenvironment and their targeting in cancer therapy.","volume":"24","author":"He","year":"2025","journal-title":"Mol Cancer"},{"key":"R30-20260827","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.3390\/cells9081785","article-title":"Role of tumor-associated myeloid cells in breast cancer.","volume":"9","author":"Cha","year":"2020","journal-title":"Cells"},{"key":"R31-20260827","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s00262-024-03699-1","article-title":"Overexpressing S100A9 ameliorates NK cell dysfunction in estrogen receptor-positive breast cancer.","volume":"73","author":"Liu","year":"2024","journal-title":"Cancer Immunol Immunother"},{"key":"R32-20260827","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3390\/curroncol32030143","article-title":"Breast cancer and tumor microenvironment: the crucial role of immune cells.","volume":"32","author":"Moura","year":"2025","journal-title":"Curr Oncol"},{"key":"R33-20260827","first-page":"e70217","article-title":"A systematic review of immune cell roles in breast cancer immunotherapy.","volume":"8","author":"Li","year":"2025","journal-title":"Cancer Rep (Hoboken)"},{"key":"R34-20260827","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1189\/jlb.4MR0216-066R","article-title":"Cellular metabolism of myeloid cells in sepsis.","volume":"101","author":"Arts","year":"2017","journal-title":"J Leukoc Biol"},{"key":"R35-20260827","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.3390\/ijms22041650","article-title":"Complementary effects of carbamylated and citrullinated LL37 in autoimmunity and inflammation in systemic lupus erythematosus.","volume":"22","author":"Lande","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R36-20260827","doi-asserted-by":"crossref","first-page":"e001910","DOI":"10.1136\/jitc-2020-001910","article-title":"Homocitrullination of lysine residues mediated by myeloid-derived suppressor cells in the tumor environment is a target for cancer immunotherapy.","volume":"9","author":"Cook","year":"2021","journal-title":"J ImmunoTher Cancer"},{"key":"R37-20260827","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s41392-023-01399-3","article-title":"Small molecule metabolites: discovery of biomarkers and therapeutic targets.","volume":"8","author":"Qiu","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"R38-20260827","doi-asserted-by":"crossref","first-page":"674192","DOI":"10.3389\/fimmu.2021.674192","article-title":"The immunology of hormone receptor positive breast cancer.","volume":"12","author":"Goldberg","year":"2021","journal-title":"Front Immunol"},{"key":"R39-20260827","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.molcel.2010.10.005","article-title":"Membranes in balance: mechanisms of sphingolipid homeostasis.","volume":"40","author":"Breslow","year":"2010","journal-title":"Mol Cell"},{"key":"R40-20260827","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/s43018-023-00527-w","article-title":"Immune landscape in invasive ductal and lobular breast cancer reveals a divergent macrophage-driven microenvironment.","volume":"4","author":"Onkar","year":"2023","journal-title":"Nat Cancer"},{"key":"R41-20260827","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41416-025-03246-4","article-title":"Steroid hormone metabolites and mammographic breast density in premenopausal women.","volume":"134","author":"Pourali","year":"2026","journal-title":"Br J Cancer"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000049014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T11:00:21Z","timestamp":1787828421000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000049014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":41,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000049014","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]},"assertion":[{"value":"2025-11-18","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-27","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}